Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Chemung Financial Corp
CHMG
$404M
| $1.25M | ﹤0.01% |
34,300
+7,400
| +28% | +$234K |
|
|
UBFO
2452
DELISTED
United Security Bancshares
UBFO
| $1.24M | ﹤0.01% |
161,763
+33,190
| +26% | +$218K |
|
|
ALDW
2453
DELISTED
Alon USA Partners LP
ALDW
| $1.24M | ﹤0.01% |
129,183
+109,983
| +573% | +$987K |
|
2454
Kamada
KMDA
$434M
| $1.24M | ﹤0.01% |
227,000
+38,500
| +20% | +$214K |
|
|
SRLP
2455
DELISTED
SPRAGUE RESOURCES LP
SRLP
| $1.24M | ﹤0.01% |
43,964
+8,364
| +23% | +$207K |
|
|
CRAY
2456
DELISTED
Cray, Inc.
CRAY
| $1.24M | ﹤0.01% |
59,651
-95,300
| -62% | -$1.96M |
|
2457
AMCON Distributing
DIT
$66.4M
| $1.23M | ﹤0.01% |
16,050
+900
| +6% | +$57.5K |
|
|
AFCO
2458
DELISTED
American Farmland Company
AFCO
| $1.23M | ﹤0.01% |
154,700
-30,303
| -16% | -$228K |
|
|
PQ
2459
DELISTED
Petroquest Energy Inc Wd
PQ
| $1.23M | ﹤0.01% |
372,189
+84,564
| +29% | +$317K |
|
|
PNRA
2460
DELISTED
Panera Bread Co
PNRA
| $1.23M | ﹤0.01% |
5,992
-145,700
| -96% | -$29.5M |
|
|
GFA
2461
DELISTED
Gafisa S.A.
GFA
| $1.23M | ﹤0.01% |
81,970
-2,959
| -3% | -$55.3K |
|
2462
AAR Corp
AIR
$5.86B
| $1.23M | ﹤0.01% |
37,060
-242,200
| -87% | -$8.34M |
|
|
SAND
2463
DELISTED
Sandstorm Gold
SAND
| $1.22M | ﹤0.01% |
312,600
-1,107,000
| -78% | -$4.64M |
|
2464
Ocular Therapeutix
OCUL
$2.13B
| $1.21M | ﹤0.01% |
+145,100
| New | +$1.13M |
|
|
OTIV
2465
DELISTED
OTI On Track Innovations Ltd
OTIV
| $1.21M | ﹤0.01% |
695,800
+400,900
| +136% | +$444K |
|
2466
Landmark Bancorp
LARK
$196M
| $1.21M | ﹤0.01% |
66,833
+17,955
| +37% | +$304K |
|
2467
Cass Information Systems
CASS
$749M
| $1.21M | ﹤0.01% |
21,648
-15,697
| -42% | -$756K |
|
|
CNH
2468
CNH Industrial
CNH
$16.8B
| $1.21M | ﹤0.01% |
159,596
-1,578,125
| -91% | -$11.1M |
|
|
IIN
2469
DELISTED
IntriCon Corporation
IIN
| $1.2M | ﹤0.01% |
174,400
-1,800
| -1% | -$11.2K |
|
|
CEA
2470
DELISTED
China Eastern Airlines
CEA
| $1.2M | ﹤0.01% |
53,800
+8,900
| +20% | +$205K |
|
|
AAMI
2471
Acadian Asset Management
AAMI
$3.3B
| $1.2M | ﹤0.01% |
82,600
-36,300
| -31% | -$515K |
|
|
WPT
2472
DELISTED
World Point Terminals, LP
WPT
| $1.19M | ﹤0.01% |
72,054
+6,561
| +10% | +$103K |
|
|
AMRN
2473
Amarin Corp
AMRN
$297M
| $1.19M | ﹤0.01% |
19,300
+16,770
| +663% | +$1.07M |
|
|
PFNX
2474
DELISTED
Pfenex Inc.
PFNX
| $1.19M | ﹤0.01% |
131,100
+14,039
| +12% | +$128K |
|
2475
Apyx Medical
APYX
$124M
| $1.19M | ﹤0.01% |
330,800
+82,400
| +33% | +$367K |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.